GoAI
Get started
Hi-CRATES CO.,LTD. logo

Hi-CRATES CO.,LTD.

4172.T

JPXHealthcareMedical - Care Facilities

Open in GoAI

Latest quote

¥2,300

+¥9.00 · +0.39%

Aug 24, 9:00 AM JST

4172.T company overview

Historical prices · Market data may be delayed.

Company profile

Company website

Hi-CRATES CO.,LTD. specializes in the creation, sale, and maintenance of comprehensive electronic medical record systems tailored for dental practices. Beyond its core EMR offerings, the company also develops and supports applications for iPads and web platforms. Its extensive product portfolio features advanced solutions such as AI and voice-activated EMRs, tools for visual and periodontal examinations, medical interview software, self-pay estimation systems, and image management. Other notable products include systems for displaying customer information during calls, managing sub-clinical records, generating treatment proposals and quotes, facilitating oral X-ray examinations, cloud-based reservation management, online consultation services, digital patient registration, and automated payment and change dispensing machines. Established in 1978, the company is headquartered in Okayama, Japan. It was previously known as TOWA Hi SYSTEM CO.,LTD., undergoing a name change to Hi-CRATES CO.,LTD. in January 2026.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
JP
CEO
Masaya Iizuka
Listed since
Dec 25, 2020
Employees
117

Market position

52-week range

Current ¥2,300

Open
¥2,300
Previous close
¥2,291
Volume
300
0.43× average
Average volume
699
Average daily volume
Market cap
5.12B JPY
Beta
0.56
Market reference 1
50-day average
¥2,201.48
+4.48% above average
200-day average
¥2,314.47
-0.63% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
4.32B JPY
EV / EBITDA
5.84×
Earnings yield
8.26%
Free cash flow yield
7.75%

Profitability & efficiency

Return on equity
10.68%
Return on assets
9.48%
Return on invested capital
8.88%

Financial health

Current ratio
5.24×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends84%57%31%5%Gross margin, FY2021: 75.28%Gross margin, FY2022: 73.55%Gross margin, FY2023: 71.51%Gross margin, FY2024: 75.76%Gross margin, FY2025: 77.01%Operating margin, FY2021: 25.39%Operating margin, FY2022: 18.80%Operating margin, FY2023: 11.31%Operating margin, FY2024: 19.97%Operating margin, FY2025: 22.83%Net margin, FY2021: 15.85%Net margin, FY2022: 14.28%Net margin, FY2023: 12.66%Net margin, FY2024: 19.01%Net margin, FY2025: 18.62%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 75.28%. Gross margin FY2022 73.55%. Gross margin FY2023 71.51%. Gross margin FY2024 75.76%. Gross margin FY2025 77.01%. Operating margin FY2021 25.39%. Operating margin FY2022 18.80%. Operating margin FY2023 11.31%. Operating margin FY2024 19.97%. Operating margin FY2025 22.83%. Net margin FY2021 15.85%. Net margin FY2022 14.28%. Net margin FY2023 12.66%. Net margin FY2024 19.01%. Net margin FY2025 18.62%.

Income trends

Revenue

2.41B JPY+13.85%

Operating income

549.61M JPY+30.17%

Net income

448.09M JPY+11.52%
Income trends across reported periods2.62B JPY1.75B JPY883.74M JPY13.33M JPYRevenue, FY2021: 2.37B JPYRevenue, FY2022: 2.22B JPYRevenue, FY2023: 2.04B JPYRevenue, FY2024: 2.11B JPYRevenue, FY2025: 2.41B JPYOperating income, FY2021: 601.6M JPYOperating income, FY2022: 416.49M JPYOperating income, FY2023: 230.93M JPYOperating income, FY2024: 422.23M JPYOperating income, FY2025: 549.61M JPYNet income, FY2021: 375.57M JPYNet income, FY2022: 316.28M JPYNet income, FY2023: 258.51M JPYNet income, FY2024: 401.81M JPYNet income, FY2025: 448.09M JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 2.37B JPY. Revenue FY2022 2.22B JPY. Revenue FY2023 2.04B JPY. Revenue FY2024 2.11B JPY. Revenue FY2025 2.41B JPY. Operating income FY2021 601.6M JPY. Operating income FY2022 416.49M JPY. Operating income FY2023 230.93M JPY. Operating income FY2024 422.23M JPY. Operating income FY2025 549.61M JPY. Net income FY2021 375.57M JPY. Net income FY2022 316.28M JPY. Net income FY2023 258.51M JPY. Net income FY2024 401.81M JPY. Net income FY2025 448.09M JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue2.41B JPY2.11B JPY2.04B JPY2.22B JPY2.37B JPY
Cost of goods sold553.42M JPY512M JPY580.76M JPY586.01M JPY585.85M JPY
Gross profit1.85B JPY1.6B JPY1.46B JPY1.63B JPY1.78B JPY
Research and development—52M JPY52M JPY6.47M JPY2.46M JPY
Selling, general, and administrative1.3B JPY1.15B JPY1.2B JPY1.17B JPY1.15B JPY
Operating expenses1.3B JPY1.18B JPY1.23B JPY1.21B JPY1.18B JPY
Interest income15.05M JPY19.11M JPY24.15M JPY16.91M JPY5.71M JPY
Interest expense————9.38M JPY
Depreciation and amortization88.4M JPY78.6M JPY68.44M JPY49M JPY35.5M JPY
Operating income549.61M JPY422.23M JPY230.93M JPY416.49M JPY601.6M JPY
Net income448.09M JPY401.81M JPY258.51M JPY316.28M JPY375.57M JPY

Company facts updated Aug 24, 2026.

Earnings

Latest fiscal-year EPS
201.13
FY2025 · +11.52% year over year
Latest fiscal-year revenue
2.41B JPY
FY2025 · +13.85% year over year

Annual EPS trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual EPS trend209.64175.6141.56107.52FY21FY22FY23FY24FY25

Annual revenue trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual revenue trend2.44B2.3B2.15B2.01BFY21FY22FY23FY24FY25

4172.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥6,987

-0.34%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,797

+0.57%

HOYA Corporation logo

7741.T

HOYA Corporation

¥24,895

0.00%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,210

+0.12%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,858

+0.86%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,406.5

+0.82%

Continue in GoAI

Research 4172.T

research.disclaimer